Metabolic syndrome: Major impact on coronary risk in a population with low cholesterol levels - A prospective and cross-sectional evaluation

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 285-292

  Onat, Altan ^a,b   Ceyhan, Köksal ^c   Başar, Ömer ^b   Erer, Burak ^d   Toprak, Sadk ^b   Sansoy, Vedat ^a,e  

^a Turkish Society of Cardiology   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Coronary heart disease; Hypertension; Insulin resistance; Lipoproteins; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DISEASE MARKER; ELECTROCARDIOGRAM; FATALITY; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; POPULATION RESEARCH; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STANDARDIZATION; TURKEY (REPUBLIC); UNITED STATES; AGED; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; EVALUATION; HYPERCHOLESTEROLEMIA; METABOLIC SYNDROME X; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BLOOD PRESSURE; CHOLESTEROL, LDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 0036889575     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00236-8     Document Type: Article

References (26)

1. Björntorp P. Visceral obesity: a 'civilisation syndrome'. Obes. Res. 1:1993;206-222.
2. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., Stern M.P. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes. 41:1992;715-722.
3. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
4. Kaplan N.M. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149:1989;1514-1520.
5. Yudkin J.S. Relationship of serum C3 complement with insulin resistance and coronary heart disease-cause, consequence or common antecedent? Eur. Heart J. 21:2000;1036-1039.
6. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Heart, Lung, and Blood Institute, NIH Publication No. 01-3670, May 2001.
7. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 156:2001;1-10.
8. Mahley R.W., Palaoǧlu E., Atak Z., et al. Turkish heart study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 36:1995;839-859.
9. Onat A., Sansoy V. Systolic and diastolic blood pressure related to six other risk parameters: strong correlation with relative weight. Int. J. Cardiol. 63:1998;295-303.
10. Onat A., Başar Ö., Keleş I., et al. Blood pressure, on prospective analysis the best predictor of coronary mortality in Turkish adults, rose by a mean of over 5/3 mmHg in the past 10 years. Arch. Turk. Soc. Cardiol. 29:2001;344-353.
11. Onat A., Avci G.Ş., Şenocak M., Örnek E., Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J. Epidemiol. Community Health. 46:1992;470-476.
12. Onat A., Şenocak M. Relative risk of factors for coronary heart disease in population with low cholesterol levels. Int. J. Cardiol. 43:1994;51-60.
13. Rose G., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular Survey Methods. 2nd ed: 1982;124-127 WHO, Geneva.
14. Lemieux I., Pascot A., Couillard C., et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 102:2000;179-184.
15. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. J. Am. Med. Assoc. 287:2002;356-359.
16. Yarnell J.W.G., Patterson C.C., Bainton D., Sweetnam P.M. Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart. 79:1998;248-252.
17. Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases. Part II. Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 104:2001;2855-2864.
18. Lemieux S., Prud'homme D., Nadeau A., Tremblay A., Bouchard C., Després J.P. Seven-year changes in body fat and visceral adipose tissue in women. Association with indices of plasma glucose-insulin homeostasis. Diabetes Care. 19:1996;983-991.
19. Meigs J.B., D'Agostino R.B.S.r, Wilson P.W., Cupples L.A., Nathan D.M., Singer D.E. Risk variable clustering in the insulin resistance syndrome. Diabetes. 46:1997;1594-1600.
20. Gray R.S., Fabsitz R.R., Cowan L.D., Lee E.T., Howard B.V., Savage P.J. Risk factor clustering in the insulin resistance syndrome: the strong heart study. Am. J. Epidemiol. 148:1998;869-878.
21. Lindblad U., Langer R.D., Wingard D.L., Thomas R.G., Barrett-Connor E.L. Metabolic syndrome and ischemic heart disease in elderly men and women. Am. J. Epidemiol. 153:2001;481-489.
22. Lemieux I., Lamarche B., Couillard C., Dagenais G.R., et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch. Intern. Med. 161:2001;2685-2692.
23. Stears A.J., Byrne C.D. Adipocyte metabolism and the metabolic syndrome. Diabetes Obes. Metab. 3:2001;129-142.
24. Onat A., Sansoy V., Yildirim B., Keleş I., Uysal Ö., Hergenç G. C-reactive protein and coronary heart disease in western Turkey. Am. J. Cardiol. 88:2001;601-607.
25. Després J.P., Couillard C., Gagnon J., et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women. The health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 20:2000;1932-1938.
26. Lean M.E.J., Han T.S., Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ. 311:1995;158-161.